Reacción a "A study in mice shows that brain stimulation using contact lenses is effective against depression"

This study has been published in the prestigious journal Cell Reports Physical Science, ensuring a peer-review process and appropriate scientific rigour in the evaluation of this new therapy based on retinal electrical stimulation. The research demonstrates that, in animal models (mice), the use of non-invasive electrical stimulation through contact lenses may be as effective as traditional pharmacological treatments for depression.

This effect could be explained by the direct anatomical connection between the retina and the brain circuits involved in mood regulation. This finding is particularly relevant as a potential alternative to pharmacological intervention, as it could allow the modulation of deep brain regions, such as the hippocampus, restoring neural connectivity without the side effects associated with medication.

However, the main limitation of the study lies in the extrapolation of the results from animal models to humans, given that there is no direct biological equivalent and that clinical trials are still required to validate both its efficacy and safety. At present, neuromodulation interventions approved by the Food and Drug Administration (FDA) for treatment-resistant depression, such as transcranial magnetic stimulation (TMS), have required a substantial body of evidence before being considered safe, and even then they still present limitations, particularly regarding the durability of their long-term effects. In this context, although this new therapeutic approach —which would operate in a manner analogous to TMS, but via the ocular pathway— represents a step towards more precise and potentially portable neuromodulation, its application in humans remains a distant prospect and will depend on overcoming several challenges, including adaptation to the human context, treatment personalisation, safety assurance, and the replicability of results.